Telsey Advisory Group Has Positive View of BBWI Q1 Earnings

Bath & Body Works, Inc. (NYSE:BBWI - Free Report) - Investment analysts at Telsey Advisory Group upped their Q1 2026 EPS estimates for Bath & Body Works in a research note issued to investors on Tuesday, May 20th. Telsey Advisory Group analyst D. Telsey now expects that the company will post earnings per share of $0.49 for the quarter, up from their previous estimate of $0.42. Telsey Advisory Group currently has a "Outperform" rating and a $43.00 target price on the stock. The consensus estimate for Bath & Body Works' current full-year earnings is $3.30 per share. Telsey Advisory Group also issued estimates for Bath & Body Works' Q4 2026 earnings at $2.21 EPS and FY2026 earnings at $3.60 EPS.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings data on Thursday, February 27th. The company reported $2.09 EPS for the quarter, beating the consensus estimate of $2.04 by $0.05. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The business had revenue of $2.79 billion during the quarter, compared to analyst estimates of $2.78 billion.

BBWI has been the subject of several other research reports. JPMorgan Chase & Co. raised their price objective on shares of Bath & Body Works from $41.00 to $43.00 and gave the company an "overweight" rating in a research note on Monday, May 19th. Barclays lifted their price target on shares of Bath & Body Works from $31.00 to $35.00 and gave the stock an "equal weight" rating in a research note on Tuesday, May 20th. Cowen reiterated a "buy" rating on shares of Bath & Body Works in a research note on Thursday, February 27th. Robert W. Baird lifted their price target on shares of Bath & Body Works from $45.00 to $47.00 and gave the stock an "outperform" rating in a research note on Friday, February 28th. Finally, Morgan Stanley decreased their price target on shares of Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating for the company in a research note on Tuesday, May 6th. Four investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company's stock. According to data from MarketBeat.com, Bath & Body Works has an average rating of "Moderate Buy" and a consensus price target of $42.56.

Bath & Body Works Price Performance

Shares of NYSE BBWI traded up $0.49 during midday trading on Thursday, hitting $30.76. The company's stock had a trading volume of 2,312,991 shares, compared to its average volume of 4,894,935. The business's fifty day simple moving average is $30.22 and its two-hundred day simple moving average is $34.03. Bath & Body Works has a 1 year low of $24.96 and a 1 year high of $52.99. The firm has a market capitalization of $6.55 billion, a price-to-earnings ratio of 7.50, a price-to-earnings-growth ratio of 0.92 and a beta of 1.87.

Institutional Trading of Bath & Body Works

Institutional investors have recently modified their holdings of the stock. Golden State Wealth Management LLC purchased a new stake in shares of Bath & Body Works during the 4th quarter worth approximately $26,000. SRS Capital Advisors Inc. increased its holdings in shares of Bath & Body Works by 99.7% in the 4th quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock valued at $26,000 after acquiring an additional 329 shares during the period. UMB Bank n.a. increased its holdings in shares of Bath & Body Works by 58.8% in the 4th quarter. UMB Bank n.a. now owns 905 shares of the company's stock valued at $35,000 after acquiring an additional 335 shares during the period. SVB Wealth LLC acquired a new position in shares of Bath & Body Works in the 1st quarter valued at $35,000. Finally, Geneos Wealth Management Inc. increased its holdings in shares of Bath & Body Works by 217.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company's stock valued at $35,000 after acquiring an additional 801 shares during the period. Hedge funds and other institutional investors own 95.14% of the company's stock.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 20th. Stockholders of record on Friday, June 6th will be given a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, June 6th. This represents a $0.80 annualized dividend and a dividend yield of 2.60%. Bath & Body Works's dividend payout ratio is presently 21.98%.

Bath & Body Works declared that its Board of Directors has approved a share repurchase plan on Thursday, February 27th that allows the company to repurchase $500.00 million in outstanding shares. This repurchase authorization allows the company to purchase up to 6.4% of its shares through open market purchases. Shares repurchase plans are often a sign that the company's board of directors believes its stock is undervalued.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.